Presentations in this session focus on strategies for improving the delivery of traditional small molecule drugs, proteins such as monoclonal antibodies, or genetic material (RNA, DNA). The route of administration can be systemic (e.g., IV, oral) or local (e.g., IM, topical), with the goal of enhancing delivery beyond current approaches. The delivery improvement can be in terms of timing, control, or dosing, but may also address challenges associated with biological responses to the delivery vehicle such as toxicity and immunogenicity.

Submit Abstract - due February 7 »

Please first review the information for authors — abstract submission guidelines.

Select Topic / Application AreaSustained/controlled releaseLigand-mediated deliveryImproved accumulation at desired siteStimulation of specific immune pathwaysAvoidance of adverse effects and toxicityRobust resistance to diseaseOtherGo